Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Baffis: Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients.... (0.11 sec) 

Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis …

- annals.org [PDF] 
V Baffis, I Shrier, AH Sherker, A Szilagyi - Annals of internal medicine, 1999 - Am Coll Physicians
The incidence of hepatocellular carcinoma in North Amer- ica is increasing.
Current debate focuses on whether inter- feron administered to cirrhotic
patients—with or without biochemical or virologic response— delays or ...
Cited by 82 - Related articles - BL Direct - All 4 versions

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based …


C Cammā, M Giunta, P Andreone, A Craxė - Journal of Hepatology, 2001 - Elsevier
Methods: Three randomized controlled trials and 15 nonrandomized controlled
trials, including 4614 patients and comparing IFN to no treatment, were
selected. Data on the incidence of HCC in IFN treated and untreated ...
Cited by 220 - Related articles - BL Direct - All 5 versions

Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic …


S Bruno, PM Battezzati, G Bellati, A Manzin, … - Journal of hepatology, 2001 - Elsevier
Results: The mean follow-up was 102±19 months. HCV RNA became undetectable in
36/47 responders. Four responders, who had remained viremic, later relapsed. The
histology progressively improved in non-viremic and viremic patients, with ...
Cited by 44 - Related articles - BL Direct - All 6 versions

Effect of interferon therapy on the development of hepatocellular carcinoma in patients with …


GV Papatheodoridis, VC Papadimitropoulos, … - Alimentary Pharmacology and Therapeutics, 2001 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 56 - Related articles - BL Direct - All 4 versions

Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis

- bmj.com
A Gramenzi, P Andreone, S Fiorino, C Camma, M … - British Medical Journal, 2001 - gut.bmj.com
PATIENTS We conducted a non-randomised prospective controlled trial at the
Department of Internal Medicine, Cardioangiology and Hepatology, University of
Bologna, that serves as a tertiary referral centre. Seventy two patients ...
Cited by 52 - Related articles - BL Direct - All 8 versions

Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon …


DC Valla, M Chevallier, P Marcellin… - Gastroenterology, 1999 - medscape.com
Journal Scan is the clinician's guide to the latest clinical research findings
in Gastroenterology, Hepatology, Gastrointestinal Endoscopy, and The New England
Journal of Medicine. Short summaries of feature articles include links to ...
Cited by 128 - Related articles - BL Direct - All 4 versions

Role of antiviral therapy in the prevention of hepatocellular carcinoma


J Franco, K Saeian - Journal of Vascular and Interventional Radiology, 2002 - Elsevier
Infection with hepatitis B and/or hepatitis C virus is strongly associated with
hepatocellular carcinoma (HCC). HCC likely develops through a sequence of
chronic inflammation to fibrosis to cirrhosis and, eventually, dysplasia. ...
Cited by 4 - Related articles - BL Direct - All 10 versions

Interferon therapy reduces the risk for hepatocellular carcinoma

- bmj.com
JL Brown - British Medical Journal, 2000 - gut.bmj.com
Multicentre retrospective cohort study of 2890 Japanese patients with hepatitis
C, of whom 2400 received interferon and 490 did not. All cases had undergone
liver biopsy within a year of commencement of treatment and minimum follow ...
Cited by 1 - Related articles - BL Direct - All 5 versions

Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C


JB Wong, GL Davis, SG Pauker - The American journal of medicine, 2000 - Elsevier
Chronic hepatitis C affects 170 million persons worldwide and nearly 3 million
in the United States [1 and 2], resulting in >8,000 deaths annually and
accounting for >20% of all liver transplants in the United States [3]. ...
Cited by 38 - Related articles - BL Direct - All 8 versions

Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis …


M Shindo, A Ken, T Okuno - CA A Cancer Journal for Clinicians - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 47 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google